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1. Introduction 
Leukemia is a classification of disease in which the two major defects are unregulated 
proliferation and incomplete maturation of the hemopoietic progenitors (Scheinberg, 
Maslak, & Weiss, 2001). Leukemia originates in the marrow, although leukemia cells may 
infiltrate lymph nodes, liver, spleen, and other tissues. Scheinberg et al. (2001) describe the 
principal clinical manifestation is the decrease of red cells and platelets as a result of the 
suppression of normal hemopoiesis or turnover and repopulation of blood components. In 
the chronic leukemias, unregulated proliferation of leukemia cells and elevated white cell 
count dominate. Differentiation and maturation of the leukemia cells may be largely 
preserved. Scheinberg further characterizes acute leukemias with unregulated proliferation 
also, but the maturation of the leukemia progenitors is profoundly impaired. 
Transplantation of blood products, in particular stem cells, has become a common treatment 
procedure for various types of leukemias since the early 1990’s (Scheinberg, Maslak, & 
Weiss, 2001). Cells void of leukemia are transplanted into the leukemia patient. The purpose 
of the transplant is the repopulation of the non-cancerous cells. Urbano-Ispizua et al. (2002) 
describes the current practice of stem cell transplantation for hematological diseases, solid 
tumors and immune disorders. Definitions, abbreviations and classifications described in 
this review are summarized here. 
Hemopoietic stem cell transplantation (HSCT) refers to any procedure where hemopoietic 
cells of any donor type and any source are given to a recipient with the intention of 
repopulation/replacing the hemopoietic system of the recipient in total or in part (Urbano-
Ispizua et al., 2002). Human Leukocyte Antigen (HLA) matching is a six point scoring 
system that identifies antigens and antibodies for both donor and recipient. Allogenic and 
autologous implants are also characterized by Urbano-Ispizua, et al (2002). Allogenic 
implants are procedures in which the recipient receives stem cells from a related or 
unrelated donor whose HLA score is identical (HLA score=6) or nearly identical (HLA 
score=5) to the recipient. Autologous implants refer to procedures in which the recipient 
receives stem cells from a collection performed while the patient is in remission or leukemia-
free.  
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Bone marrow and cerebral spinal fluid peripheral cells are standard sources of hemopoietic 
stem cells (Urbano-Ispizua et al, 2002). For autologous HSCT, peripheral blood has become 
the preferred choice in view of its more rapid hemopoietic reconstitution. For allogenic 
HSCT, both sources are used. Both methods have their specific advantages and 
disadvantages. There are marked differences in toxicity concerning the donors. For 
recipients, the final issue concerning long-term outcome remains open. Peripheral blood is 
associated with more rapid engraftment or repopulation in the recipient. Urbano-Ispizua 
(2002) warns of a major concern with allogenic transplantation with peripheral blood is the 
high incidence of chronic graft-versus-host disease. That is, the recipient’s immune system 
rejects the donor cells. In general, cord blood transplantation is recommended when patients 
require allogenic transplantation and do not have an HLA identical or a one-antigen 
mismatched donor. 
Both allogenic and autologous implants are performed subsequent to subjecting the 
leukemia patient to intensity conditioning regimens (Shank, 1998). Despite the classification 
of the patient as in remission or disease-free, there is still significant opportunity that 
undetected leukemia cells are still present and will repopulate along with the transplanted 
stem cells. Shank describes the conditioning regimen’s intent is to reduce the likelihood of 
the leukemia cell re-growth. Conditioning regimens include intense chemotherapy or 
radiation therapy or a combination of both. The intensity of these treatments is severe. 
Shank cautions of the fine balance between transplant-related mortality and the risk of 
relapse or repopulation of the leukemia cells. 
The role of radiation therapy in the preparation of patients for bone marrow transplantation 
is the primary focus of this chapter. The primary utilization of radiation in oncology 
management is the use of small (less than 100 sq.cm) beams or fields directed at localized 
solid tumors (Bentel, 1992). Since leukemia cells are present throughout the body, large 
fields encompassing the entire body are necessary. This type of radiation treatment is 
referred to as Total Body Irradiation (TBI) or sometimes as Magna Field Irradiation (Shank, 
1998). In her review article, Shank cites sole use TBI did not eradicate all leukemia cells. The 
addition of chemotherapy such as cyclophosphamide (CY) provides a reduced recurrence 
rate. Shank notes that although a large number of regimens now combine chemotherapeutic 
agents with and without TBI for marrow ablation, combined therapy of CY and TBI remains 
the standard for comparison. 
Irradiation holds several advantages over chemotherapy as a systemic agent (Shank, 1998). 
These advantages include a lack of crossreactivity with other agents, dose homogeneity 
independent of blood supply, no requirements for detoxification and excretion, and the 
ability to tailor dose distribution within the body by shielding areas of greater sensitivity or 
boosting the radiation dose in areas that may contain additional disease. This discussion will 
focus primarily on the clinical aspects of TBI. Technical aspects of providing these large 
fields will also be addressed..  
2. Total body irradiation: Criteria and nuances 
Bentel (1992) describes standard methodology of radiation oncology treatments. Standard 
radiation therapy treatments are provided utilizing a linear accelerator with x-ray energies 
approximately 100 times greater than conventional machines used for chest or dental x-rays. 
The accelerator is capable of rotating 360 degrees about a patient with the center of rotation 
placed within the tumor volume. Typically, 2-6 fields or beams are directed at the tumor 
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volume from various angles. A criterion for field arrangement is accounting for dose 
uniformity within the tumor volume. That is, large variations in dose throughout the tumor 
are rarely acceptable. Bentel continues by specifying that additional beams will aid with 
dose uniformity. Beam angulation is determined by the desire to “spare” or reduce the 
radiation dose to non-malignant or non-cancerous tissue or organs. In most cases, the 
delivered radiation dose to the tumor is limited by normal tissue or organ tolerance in areas 
surrounding or close to the tumor volume (Bentel, 1997). Radiation doses are expressed in 
units of centigray (cGy) which is equivalent to the more common unit rad. Typical dose 
levels for standard non-TBI treatments are 4500-7000 cGy. Field dimensions are usually 100-
200 sq.cm therefore; the fields are roughly 5 inches by 5 inches. Dose uniformity criteria is 
typically +/- 5%. The standard treatment distance from the housing of the accelerator is 
100cm. 
Van Dyk (2000) addresses the degree of accuracy required for total body irradiation 
treatments. As the specification of dose becomes less certain, disease control can be affected. 
In addition, undesirable radiation induced side effects can be pronounced. Van Dyk cites 
research that a 5% change in dose could result in a 20% change in the incidence of radiation 
pneumonitis. Under such circumstances, it is difficult to argue that +/- 5% accuracy is 
sufficient. Conversely, if the prescribed dose is well below the onset of radiation 
pneumonitis and if the dose is sufficient for adequate tumor control, then perhaps the 
guideline of +/- 5% accuracy can be relaxed and +/- 10% or even +/- 15% may be 
sufficiently accurate. The beam arrangement for total body irradiation is typically chosen 
with +/- 10% accuracy and uniformity criteria. 
For large field radiotherapy, the delivery of a uniform dose of radiation over the entire 
target volume is not a trivial task. The irradiation method must be devised to produce 
radiation fields large enough to cover the entire body adequately. With this larger field size 
requirement, the patient is positioned further from the linear accelerator than the standard 
100cm treatment distance. The increased distance takes advantage of the spread or 
divergence of the radiation field from the accelerator. The treatment distance can vary 
depending on the accelerator vault size, but is typically 350 to 500cm. The treatment 
distance for the TBI procedure represents a few additional problems (Lindsey & Deeg, 1998). 
These distances can be difficult to achieve in some linear accelerator vaults. Counter tops or 
other equipment will need to be removed. Since the patient will not be on the standard 
treatment couch at this extended distance, another adjustable patient support table must be 
acquired or fabricated.  
Dose uniformity is a major concern for the TBI process and the technique option chosen 
(Bradley et al., 1998). Bentel (1992) describes the principle of radiation absorption. The 
absorption of radiation is exponentially proportional to the thickness of the different body 
sections of the patient. The variance between absorption and dose between thinner and 
thicker body sections is more pronounced as the x-ray energy is decreased. Therefore, 
higher x-ray energy aids the dose uniformity criteria. Fletcher describes a negative side to 
the use of higher x-ray energy. Unfortunately, higher x-ray energies provide decreased 
entrance dose with the first 2cm of the patient. That is, high energy x-rays will provide a 
more uniform dose in tissue only after the first 2cm. Therefore, the use of a x-ray energy 
greater than 4MV require the addition of an acrylic sheet placed in close proximity to the 
patient (Bradley et al., 1998). This acrylic sheet serves as a “beam spoiler” and produces 
scatter radiation that allows the entrance 2cm of tissue to receive a higher and more 
adequate dose. 
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Even with the use of high-energy x-rays and beam spoilers, the dose uniformity across the 
patient and from thicker to thinner body sections may not meet the +/- 10% criteria 
(Bredeson et al., 2002). Dose uniformity will improve if opposed beams are used. As shown 
and described in Figure 1, the beam can be directed from different sources (item d) or by 
changing the patient position from supine to prone. If a two-beam arrangement is utilized, 
half of the radiation dose is provided by one beam. The patient is rotated or the source of 
radiation is moved and the remaining dose is provided. Typically, two fields are adequate to 
provide acceptable dose homogeneity for TBI treatments (Bredeson et al., 2002). 
 
 
Fig. 1. Front view of TBI table used for opposed lateral treatments with couch sections 
angled at 45°. 
Large variations in patient thickness, e.g. head thickness compared to shoulder thickness, 
pose problems with dose uniformity that multiple fields cannot resolve (Bredeson et al., 
2002). Galvin and D’Angio and Walsh (2000) and Lin and Chu (2001) have described 
methods for compensating for the lack of patient thickness in certain areas such as the head 
or feet. The addition of rice bags or water-filled bags serves as adequate substitutes in these 
areas of decreased thickness. Rice or water exhibits the same attenuation characteristics as 
human tissue. Therefore, packing the patient or filling voids with these materials presents 
the patient as a uniform thickness. Therefore absorption variations are minimized.  
The parameters used to characterize the x-ray beam at the standard 100cm distance will not 
necessarily apply to the extended distance (Van Dyk, 2000). Beam profiles and output 
calibration of the linear accelerator at the treatment position will need to be measured. 
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Verification of the attenuation of the beam should be made with anthropomorphic or tissue 
equivalent phantoms. Scatter radiation from other components within the room, such as 
walls and equipment, will apply to this extended distance large field treatment and should 
be accounted. 
One of the major complications of large field radiotherapy is radiation pneumonitis (Corns 
et al., 2000). For total lung radiation, this syndrome is lethal in 80% of the patients who 
develop it. Because of this effect, Corns et al. (2000) warns that it is imperative that the dose 
to the lung be precisely controlled to ensure the probability of its occurrence is minimal. 
Even in standard radiation treatments, a calculation of the lung dose requires density 
corrections to the standard attenuation data (Bentel, 1992). The lower density lungs will 
transmit more radiation than regular more dense tissue. Several methods have been 
developed to correct for the lower density lung tissue and provide an accurate accounting of 
dose in this region (Bentel, 1992). Unfortunately, these calculations vary in ease of use as 
well as in the resulting correction factor. Van Dyk (2000) has calculated the correction factor 
from four of the most popular methodologies and observed a +/-12% variation. Despite this 
variation in accounting accuracy, methods of lung dose reduction is often required (Van 
Dyk, 2000). 
When a prescribed tumor dose is well above lung tolerance, the dose to lung will have to be 
reduced to minimize the probability of lung complication. Several methods can be used to 
reduce the dose. The techniques vary in complexity of design and application. All 
techniques incorporate one common concept: the use of an attenuator (Van Dyk, 2000). The 
attenuator absorbs radiation prior to delivering dose to the lungs. The decreased dose 
delivered to the lungs coupled with the increased transmission of dose within the lungs 
because of their lower density provides a dose comparable to rest of the body. Van Dyk 
describes several methods for the design of these attenuators. These methods vary from 
shielding the lungs with arm positioning to full or partial-transmission shielding blocks 
based on Computerized Tomography scans. 
3. Representative Total Body Irradiation program 
A representative TBI program is described here as an aid to the development of similar 
programs. Room modifications, technique selection, energy choice, and equipment 
necessary to achieve adequate dose uniformity in a comfortable setting are included in this 
discussion.  
3.1 Accelerator room 
TBI treatments should be performed with a high energy accelerator capable of providing 
photons of 15MV or greater. Lower x-ray energies can be utilized, but as the energy is 
decreased, dose homogeneity becomes more difficult to achieve with opposed fields. The 
distance to the closest wall with the gantry angled at 90 or 270 degrees will dictate the 
maximum field size to encompass the patient. Offset of the isocenter in the treatment vault 
design may allow for a greater treatment distance. Unfortunately, the desire to add TBI to 
the radiation therapy services may occur after a vault has been constructed. Most vaults are 
configured with a 20 foot width. Without an isocenter offset, this room width provides a 
source-wall distance of approximately 4m. Our institution’s vault design provided a source-
wall distance of slightly less than 4m. A 40x40 cm2 field at 1m projects to 1.58m2 without 
collimator rotation and 2.2m2 with a 45° collimator rotation. Only a minor room 
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modification may be necessary to provide audio and visual communication with a patient 
positioned at this location.  
3.2 Opposed lateral field TBI table 
A portable surgical couch was obtained from a medical equipment reclamation firm. This 
modified couch is utilized for providing TBI treatments with opposed lateral fields. It is the 
technique of choice where treatment goals include dose uniformity without specific organ 
blocking. Figure 1 is a front view schematic of the couch arrangement. The effective length 
of the patient was reduced as sections of the couch are angled 45°. Four inch urethane foam 
cushions are used to separate the patient from any metal located on the couch. An 
additional egg crate cushion is provided for patient comfort. The couch height is adjusted 
vertically to coincide with the isocenter height of 1.3m.  
After patient positioning, four beam spoiler plates constructed of ¼" lexan polycarbonate are 
inserted into aluminum slots added to the couch. The width of the treatment table including 
the lexan polycarbonate plates is 52cm. Factoring in couch clearance to the wall, the source-
tray distance for these lateral treatments is 374 cm. Our wall choice required a gantry angle 
selection of 270° (IEC). A collimator position of 20° and 340° is used for right lateral and left 
lateral fields, respectively. 
Prior to treatment, a head and neck missing tissue compensator is positioned. An acrylic 
compensator is secured to a tray and supported with the accelerator hand support which is 
affixed to the accelerator couch rail (Fig. 2). The compensator angle position can be pivoted 
on the tray to match each patient. The compensator tray is rotated for the opposing lateral 
treatment and the couch longitudinal position is adjusted accordingly. The compensator 
bottom is curved to match the alignment between the patient neck and shoulders.  
Tissue-equivalent rice bolus is used for additional missing tissue compensation for the body 
below the patient neck level. Figure 3 demonstrates the bolus placement. Since the patient's 
torso represents the widest section of the patient, bolus is typically only provided below the 
waist level between and around the legs and feet. The rice bag placement essentially makes 
the patient separation constant below the neck level and matching the maximum torso 
separation. Since the dose prescription point is typically at mid-depth at the umbilicus level. 
Tubes of rice and smaller individual plastic bags of rice with disposable outer covering are 
used for this aspect of patient preparation.  
This treatment assumes that the treatment goal is to provide the same dose to the lungs as 
provided at the mid-umbilicus level. Prior to treatment, a lateral separation is determined at 
the nipple level. Previous chest x-ray review for over 50 patients revealed a relationship 
between this separation and the lateral width of the lungs. Of the lateral tissue separation, 
77-83% of the tissue was comprised by the lower density lungs. Rather than measuring the 
lung width with a chest x-ray on each patient, we calculate the lung thickness as 80% of the 
full tissue thickness and assume a lung physical density of 0.35g/cm3. An effective thickness 
at this level is determined.  
The arms are positioned at the patient's side thus adding higher density thickness to the 
chest area (Fig. 3.). The arm separation is determined and added to the effective thickness. 
This total is compared to umbilicus separation. If additional thickness is needed at the arm 
level to meet the thickness uniformity criterion of +/-1cm, additional “bolus with skin” 
(CIVCO, Orange City, IA) is added around the arm in 0.5cm increments until this criterion is 
met. A simple spreadsheet is used to perform these calculations as well as print setup 
instructions. 
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Fig. 2. Acrylic head and neck compensator mounted on post connected to accelerator couch 
rail arm support. 
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Monitor unit settings are calculated for the mid-depth at the umbilicus level. In-vivo 
entrance and exit dosimeters are placed at the head, neck, nipple, umbilicus, knee and ankle 
levels. After delivery of one half of the fractional dose, the patient remains positioned and 
the table is rotated 180°. The collimator is rotated to correspond to the new lateral 
orientation. The head and neck compensator is repositioned. The remainder of the treatment 
is provided. The dose rate from the accelerator is reduced between 100-200MU/min at 
isocenter. This machine dose rate reduction, the measured distance correction output factor, 
and attenuation will provide a dose delivery near 7cGy/minute. Dose rate has been 
determined to have a significant effect on lung toxicity. Most treatment protocols require 
dose delivery less than 10cGy/minute. Treatment times are approximately 15 minutes per 
field. This method of TBI delivery offers a uniform dose, easy and reproducible field 
arrangement, and a comfortable patient setup. 
 
 
Fig. 3. Schematic of patient on TBI table with beam spoilers and rice bolus in place. 
3.3 AP/PA TBI treatment stand 
The opposed lateral field TBI table method does not allow for partial transmission blocking 
of the lung or liver as required by various protocols. Towards this goal, an alternative stand 
was developed to accommodate AP/PA field arrangement, cerrobend blocking, and 
verification of block placement in a reproducible and comfortable environment for the 
patient. The initial design of this stand utilized specifications described previously.6,7 Over 
the years, significant modifications to these designs have been made largely to 
accommodate weak patients who had difficulty standing for lengthy periods. The majority 
of patients presenting for TBI have received a chemotherapy regimen as a complementary 
preparation before the transplant. 
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The current version of the AP/PA TBI stand is pictured in Figure 4. Detailed drawings 
describing the construction of this stand are available from the authors to aid in duplicating 
this construction. The stand begins with a 29"(w)x29"(l)x27"(h) wooden platform. This 
height allows field coverage at the treatment distance with the accelerator gantry positioned 
at 272° and a collimator rotation of 45°. A patient rehabilitation walker was affixed to the 
platform after wheel removal. The cushioned arm supports can be positioned at varying 
levels to accommodate different patient heights.  
A fabric harness is attached around the patient's waist and thighs. This harness is then 
attached with plastic buckles to the frame of the walker support. The harness system 
provides the patient significant stability and tolerance for the required lengthy standing 
time for this procedure. Patients have experienced episodes of significant weakness or even 
fainting and the harness system allowed potential injury to be avoided before care could be 
offered to the patient. 
Additional patient support and comfort is provided by an adjustable bicycle seat attached to 
a slide affixed to the platform. The current seat arrangement represents the evolution from a 
seat supported from the platform rear to a single post from the platform middle. Other 
stools were investigated and rejected due to adjustment restrictions or beam attenuation. 
The blocking support is attached to a portable beam spoiler (Fig. 5). The plastic spoiler is 
fabricated with 3/8” lexan polycarbonate and supported on a mobile assembly that is 
positioned directly in front of the patient after configuring the patient on the harness and 
stool. Angle iron is placed on the sides of the beam spoiler away from the beam to provide 
additional rigidity when the blocks are added. Again, detailed drawings are available from 
the authors upon request. 
The cerrobend partial transmission blocks are affixed to a separate ¼” lexan tray. The 
blocking tray is supported on a tray slot placed on each side of the bam spoiler. The 
thickness of the transmission blocks is calculated utilizing attenuation properties measured 
previously. The block thickness also varies with the patient separation and the desired 
transmitted dose, 8 or 10Gy. Typical thickness varies between 2-4cm of cerrobend and is 
determined using a simple spreadsheet calculation. 
The positioning of the block is verified with imaging. In our case, we utilize the Kodak ACR 
2000 CR system. However, a film cassette requiring chemical processing could also be used. 
Fig. 4 also shows a cassette holder attached to the rear of the platform. This spring-loaded 
cassette holder allows easy height adjustment and was obtained from a medical equipment 
reclamation service for less than $50. If lateral adjustment in block placement is necessary 
after imaging, the blocking tray can be adjusted horizontally using a top-loaded bearing 
system. This adjustment provides +/- 7cm adjustment. Refer to the appendix for details. 
Two worm screws are added to the sides of the block assembly and vertical adjustment is 
accomplished by cranking up or down along this mechanism. After an acceptable image is 
obtained, the block shadow is traced onto the patient’s surface for subsequent fractions.  
As with the opposed lateral TBI treatment, the accelerator output rate is adjusted such that 
the midline dose rate is less than 10cGy/minute. Entrance and exit in-vivo dosimeters are 
placed to verify dose uniformity. Since the hands and forearms are not placed at the 
patient’s side, but on the cushioned arm supports, there was a concern about dose 
uniformity in this region. Measurements confirm uniformity within +/- 5% as the hands and 
forearms are closer to the beam during the anterior field treatment and further from the 
beam during the posterior field delivery. 
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Fig. 4. Front view of TBI stand used for AP/PA fields. 
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Fig. 5. Front view of mobile spoiler and blocking mechanism used in conjunction with TBI 
stand. 
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3.4 Combination of treatment methods 
Despite efforts to provide a comfortable treatment in the TBI stand, the opposed lateral TBI 
table still is viewed as the most comfortable for patients and easy to set up. Patients 
receiving TBI that requires dose reduction to the lungs and/or liver are treated using a 
combination of these two techniques. All current protocols requiring dose reduction to these 
organs require treatments to be administered over four days or 8 fractions. We routinely 
treat 4 fractions with the AP/PA TBI stand technique and 4 fractions with the opposed 
lateral TBI table option.  
4. Radiobiological considerations for Total Body Irradiation 
The techniques and methodology described in the previous section account for the physical 
criteria and limitations for the TBI procedure. The actual dose prescription and dose 
delivery schedule also play an important role in the success of the procedure (Shank, 1999). 
Normal lymphocytes are among the most radiosensitive cells and become profoundly 
depleted with TBI (Shank, 1999). In addition to finding that TBI was more 
immunosuppressive than CY, Shank describes early animal studies that found the degree of 
immunosuppression was a function of the total radiation dose. Dividing the treatment into 
multiple fractions over several days required an increase in total dose to achieve consistent 
results. Shank states the need for an increased dose over a fractionated schedule implies 
repair processes occurring between fractions. 
Radiobiologists categorize the repair process from fractionated radiation treatments as 
repair, reoxygenation, redistribution and repopulation (Evans, 2000). In the context of TBI as 
applied to bone marrow transplantation, Evans states repair and repopulation are probably 
the most significant of these processes and can be best explained with a cell survival curve 
as shown in Figure 6. The slope of a survival curve can describe the radiation sensitivity of a 
particular cell type. The slope of the curve, termed Do and the shoulder region, termed Dq, 
quantify significant parameters of a cells response to radiation. Cells from different tissues 
have different Do’s and Dq’s as illustrated in Figure 6. 
It has been generally accepted that a small shoulder (Dq) is typical of bone marrow stem 
cells and leukemia cells (Evans, 2002). Therefore, these cells have a limited ability to repair 
damage. In contrast, cells of lung tissue and intestinal epithelial cells have survival curves 
with must broader shoulders (Dq), implying a greater repair capacity. The second important 
repair process is repopulation. Evans defines repopulation as the proliferation of cells 
between dose fractions. Rapidly dividing tissues, like the intestine, can increase their normal 
proliferation rate after a radiation treatment. Slowly dividing tissues such as the lung and 
vascular tissues tend not to proliferate at a higher rate after radiation. Therefore, during a 
fractionated radiation therapy regimen, Evans speculates that both repair and repopulation 
may occur between fractions. Repair of the leukemia cells is minimal. The separation of the 
leukemia cell survival curve from the lung cell survival curve increases the therapeutic ratio 
and supports fractionation. Shank (1998) attempted to calculate the optimal TBI schedule 
including fraction dose, number of fractions, and total dose. In addition, Shank reviews 
some clinical trials with regards to percentage relapse with different TBI schedules. Shank 
summarizes her findings that the greatest leukemia cell kill with minimum morbidity will 
occur with a highly fractionated radiotherapy regimen. A total dose of 1400-1500 cGy 
delivered over 10-13 fractions may be optimal. 
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Fig. 6. A typical survival curve for mammalian cells exhibiting an initial shoulder followed 
by an exponential region. An initial shoulder characterizes the curve with some slope to it 
(1Do), the exponential slope (Do), n (extrapolation number) and Dq. 
5. Effectiveness of TBI for various leukemias 
Leukemia is a broad classification for several types of this disease. This variety of leukemias 
differs based on pathological examination of cell definition. Bredeson et al. (2002) provide a 
summary and results of clinical trials including TBI. Patients with acute myeloid leukemia 
(AML) have shown to be fairly responsive to stem cell transplants with TBI preparation. 
Results of randomized studies comparing TBI containing regimens with total chemotherapy 
preparatory regimens indicate a 75% actuarial survival with TBI compared to 51% without. 
Relapse rates are lower with the TBI regimens as well. 14% relapsed within 2 years with TBI 
while 34% relapsed under chemotherapy regimens. 
Bredeson et al. (2002) reports acute lymphoblastic leukemia (ALL) results show significant 
improvement with TBI regimens. 52% disease-free survival rates are reported when TBI is 
utilized as compared to 37% with chemotherapy alone. The percentage relapse is nearly 
identical from both types of regimens. Studies of treatments for chronic myeloid leukemia 
patients show fairly high yet identical disease-free survival rates. Nearly 80% survival rates 
were reported for both protocols. Relapse rates were indistinguishably different. 
6. Discussion and summary 
Leukemia is a disease classification for an imbalance within the hemopoietic system. Acute 
leukemias are characterized with unregulated cell growth while chronic leukemias exhibit 
incomplete maturation of cells and some increase proliferation. Bone marrow or stem cell 
transplantation is a viable treatment option for the leukemia patient. Stem cells collected 
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from an HLA matching donor or cells collected from the patient while in remission are 
provided to the leukemia recipient. The clinical desire of the transplant is repopulation and 
re-growth of the stem cells triggering a balanced regulated hemopoietic system.  
Preparative regimens for marrow transplantation are required to rid the leukemia patient of 
any microscopic disease. Rigorous protocols of chemotherapy or radiation therapy 
combined with chemotherapy are provided prior to transplantation to reduce relapse. 
Radiotherapy includes fractionated treatments delivered to the total body (TBI). TBI 
treatments pose several concern issues in methodology and fractionation. High-energy 
fields with opposing beam arrangements lead to improved dose uniformity. Acrylic plates 
can serve as beam spoilers to increase the dose to an adequate dose for shallow depths. The 
lung tissue is sensitive to radiation and limits the dose delivered to the rest of the body. 
Accurate lung dose calculations are necessary to determine if attenuators are necessary to 
reduce the total lung dose. Fractionation of the TBI dose requires an increase in the total 
dose delivered as repair and repopulation occurs between fractions. Repair processes are 
minimal for the leukemia cell and therefore the therapeutic ratio is enhanced. Analysis of 
the disease-free survival rates and evaluation of the percentage of patients relapsing or 
recurring measure the effect of these preparatory regimens. TBI shows a marked 
improvement in both factors for AML and ALL. Studies reviewing the effects of treatments 
for CML show excellent results for both chemotherapy only protocols and TBI-
chemotherapy combined protocols.  
Over the last 35 years, TBI delivery protocols have evolved due to toxicity concerns. Radiation-
induced toxicity is influenced by the dose rate and total dose. The total dose was 
predominantly restricted by pulmonary toxicity from interstitial pneumonitis. Single fraction 
TBI was replaced with fractionated and hyperfractionated techniques. Radiobiological 
principles of preferential normal tissue repair with fractionation forecast improved anti-
leukemic effects without increasing toxicity. Dose rate was considered a strong factor in the 
causation of interstitial pneumonitis and most protocols restrict the delivery dose rate to less 
than 10 cGy/min. TBI protocols vary with the primary malignancy and complementary 
chemotherapy conditioning regimen. Current TBI protocols include: a single fraction of 200 
Gy; two BID fractions of 2 Gy/fraction; eight BID fractions of 1.5 Gy/fraction with or without 
lung and liver dose reduction to 8-10 Gy; and eight BID fractions of 1.65 Gy/fraction with or 
without partial transmission blocking of the lung and liver. 
Factors influencing large field treatment technique choice include dose homogeneity, 
accurate and reproducible delivery, ease of set up, treatment room limitations, and the 
treatment protocol used. For example, if a reduced organ dose is required with blocking, an 
AP/PA treatment technique is required. Different techniques have been described recently 
including those utilizing tomotherapy or translational couch options. Two methods of 
comfortable total body irradiation using conventional linear accelerators without machine 
modifications are presented here. A technique for lateral treatments and a process for 
AP/PA treatments with blocking are described. Techniques described here enhance other 
reported design specifications. The technique options represent an evolution in our process 
and should aid facilities looking to begin a TBI program or facilities desiring modifications 
to adjust to different treatment protocols. 
Dose uniformity is the primary criterion when creating a treatment technique. The use of 
beam spoilers, strategically placed bolus, missing tissue compensators, and opposed fields 
with high energy x-rays will accomplish the uniformity goal. While dose uniformity is the 
major priority in developing a suitable treatment technique, patient comfort and support are 
equally important. Patients presenting for TBI are often weak and recovering from other 
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chemotherapy treatments as part of the preparatory program for transplant. Two treatment 
options, opposed laterals and AP/PA fields and associated apparatus have been presented. 
The limitation of dose delivered to the lung/liver is specified in several protocols and is 
accomplished with partial transmission blocks placed in conjunction with AP/PA fields. 
Both techniques were designed to insure accurate dose delivery, comfortable patient 
support, and easy patient setup. Calculation spreadsheets referenced in this manuscript are 
available by contacting the authors.  
7. Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 1. 5/8” stainless steel rod, 2. Angle iron for stabilization and support, 3. Adjustable cassette 
holder, 4. Double track system support for bicycle seat placement, 5. Platform with ¾”plywood on oak 
framework 
Fig. A-1 Front and side view of AP/PA stand . 
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Legend: 1. 5/8” stainless steel rod, 2. Angle iron for stabilization and support, 3. Adjustable cassette 
holder, 4. Double track system support for bicycle seat placement, 5. Platform with ¾”plywood on oak 
framework 
Fig. A-2 AP/PA Stand Side View 
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Legend: 6. 1-1/2”x3-1/2” Oak frame support, 7. Lexan beam spoiler, 8. Support for block tray with 
galvanized metal support, 9. Galvanized metal lock, 10. Crank, 11. Bearing location & cap (2 
bearings/crank), 12. Ball bearing track for horizontal block adjustment, 13. ¼” block tray, 14. 7/16” 
thread rod,  15. ¼” channel for rod adjustment system 
Fig. A-3 AP/PA Beam Spoiler and Blocking Support Front View 
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Legend: 6. 1-1/2”x3-1/2” Oak frame support, 7. Lexan beam spoiler, 8. Support for block tray with 
galvanized metal support, 9. Galvanized metal lock, 10. Crank, 11. Bearing location & cap (2 
bearings/crank), 12. Ball bearing track for horizontal block adjustment, 13. ¼” block tray, 14. 7/16” 
thread rod,  15. ¼” channel for rod adjustment system 
Fig. A-4 AP/PA Beam Spoiler and Blocking Support Side View 
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